TNON vs. GCTK, SONX, STSS, SINT, HSDT, NUWE, BBLG, SIENQ, BJDX, and ANZUW
Should you be buying Tenon Medical stock or one of its competitors? The main competitors of Tenon Medical include GlucoTrack (GCTK), Sonendo (SONX), Sharps Technology (STSS), Sintx Technologies (SINT), Helius Medical Technologies (HSDT), Nuwellis (NUWE), Bone Biologics (BBLG), Sientra (SIENQ), Bluejay Diagnostics (BJDX), and Anzu Special Acquisition Corp I (ANZUW). These companies are all part of the "medical equipment" industry.
GlucoTrack (NASDAQ:GCTK) and Tenon Medical (NASDAQ:TNON) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, media sentiment, community ranking, valuation, risk, institutional ownership, profitability, analyst recommendations and dividends.
GlucoTrack has a net margin of 0.00% compared to GlucoTrack's net margin of -445.77%. Tenon Medical's return on equity of -207.55% beat GlucoTrack's return on equity.
Tenon Medical received 3 more outperform votes than GlucoTrack when rated by MarketBeat users.
Tenon Medical has a consensus price target of $3.00, indicating a potential upside of 370.29%. Given GlucoTrack's higher probable upside, analysts plainly believe Tenon Medical is more favorable than GlucoTrack.
In the previous week, GlucoTrack and GlucoTrack both had 2 articles in the media. Tenon Medical's average media sentiment score of 1.43 beat GlucoTrack's score of 0.44 indicating that GlucoTrack is being referred to more favorably in the media.
GlucoTrack has higher earnings, but lower revenue than Tenon Medical. GlucoTrack is trading at a lower price-to-earnings ratio than Tenon Medical, indicating that it is currently the more affordable of the two stocks.
10.9% of GlucoTrack shares are held by institutional investors. Comparatively, 22.7% of Tenon Medical shares are held by institutional investors. 17.7% of GlucoTrack shares are held by company insiders. Comparatively, 4.7% of Tenon Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
GlucoTrack has a beta of 0.06, meaning that its share price is 94% less volatile than the S&P 500. Comparatively, Tenon Medical has a beta of 2.18, meaning that its share price is 118% more volatile than the S&P 500.
Summary
GlucoTrack and Tenon Medical tied by winning 7 of the 14 factors compared between the two stocks.
Get Tenon Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for TNON and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TNON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Tenon Medical Competitors List
Related Companies and Tools
